Related references
Note: Only part of the references are listed.Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
Frank G. Holz et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Cost-utility Analysis of Screening for Diabetic Retinopathy in Japan: A Probabilistic Markov Modeling Study
Ryo Kawasaki et al.
OPHTHALMIC EPIDEMIOLOGY (2015)
Assessment of vision-related quality of life among patients with cataracts and the outcomes of cataract surgery using a newly developed visual function questionnaire: the VFQ-J11
Yoshimune Hiratsuka et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2014)
Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study
Emily Y. Chew et al.
OPHTHALMOLOGY (2014)
Progress on retinal image analysis for age related macular degeneration
Yogesan Kanagasingam et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2014)
Effect of Long-Chain ω-3 Fatty Acids and Lutein plus Zeaxanthin Supplements on Cardiovascular Outcomes Results of the Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
Denise E. Bonds et al.
JAMA INTERNAL MEDICINE (2014)
The impact of a better-seeing eye and a worse-seeing eye on vision-related quality of life
Christoph Hirneiss
CLINICAL OPHTHALMOLOGY (2014)
Prevalence and Characteristics of Age-Related Macular Degeneration in the Japanese Population: The Nagahama Study
Isao Nakata et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Lutein plus Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
Emily Y. Chew et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Cost-utility analysis of cataract surgery in Japan: a probabilistic Markov modeling study
Yoshimune Hiratsuka et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2013)
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Soraya Rofagha et al.
OPHTHALMOLOGY (2013)
Association of ARMS2 Genotype With Bilateral Involvement of Exudative Age-Related Macular Degeneration
Hiroshi Tamura et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010
Sara Brandi Bloch et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration
Sreekumari Pushpoth et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Incidence of Endophthalmitis and Use of Antibiotic Prophylaxis after Intravitreal Injections
Crystal S. Y. Cheung et al.
OPHTHALMOLOGY (2012)
One Eye or Two: A Comparison of Binocular and Monocular Low-Contrast Acuity Testing in Multiple Sclerosis
Stacy L. Pineles et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cost Effectiveness of Treatments for Wet Age-Related Macular Degeneration
Paul Mitchell et al.
PHARMACOECONOMICS (2011)
EXTEND-I: safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
Yasuo Tano et al.
ACTA OPHTHALMOLOGICA (2010)
Cost-Effectiveness of Ranibizumab for the Treatment of Neovascular Age-Related Macular Degeneration in Germany: Model Analysis From the Perspective of Germany's Statutory Health Insurance System
Aljoscha S. Neubauer et al.
CLINICAL THERAPEUTICS (2010)
Nutritional supplements for age-related macular degeneration
Nupura Krishnadev et al.
CURRENT OPINION IN OPHTHALMOLOGY (2010)
Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration
Luis Javier Hernandez-Pastor et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
INTERNATIONAL SURVEY ON WILLINGNESS-TO-PAY (WTP) FOR ONE ADDITIONAL QALY GAINED: WHAT IS THE THRESHOLD OF COST EFFECTIVENESS?
Takeru Shiroiwa et al.
HEALTH ECONOMICS (2010)
Phenotype and Genotype Characteristics of Age-related Macular Degeneration in a Japanese Population
Keisuke Mori et al.
OPHTHALMOLOGY (2010)
Nine-Year Incidence and Risk Factors for Age-Related Macular Degeneration in a Defined Japanese Population The Hisayama Study
Miho Yasuda et al.
OPHTHALMOLOGY (2009)
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): Year 2 results
Andrew N. Antoszyk et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration
Takashi Ueta et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1
Carl D. Regillo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Global Vision Impairment Due to Uncorrected Presbyopia
Brien A. Holden et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Cost-Effectiveness of Ranibizumab Compared with Photodynamic Treatment of Neovascular Age-Related Macular Degeneration
Luis Javier Hernandez-Pastor et al.
CLINICAL THERAPEUTICS (2008)
Cost-effectiveness sequential modeling of ranibizumab versus usual care in age-related macular degeneration
S. Y. Cohen et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Medical progress: Age-related macular degeneration
Rama D. Jager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration
Melissa M. Brown et al.
OPHTHALMOLOGY (2008)
Computerized Model of Cost-Utility Analysis for Treatment of Age-Related Macular Degeneration
E. C. Fletcher et al.
OPHTHALMOLOGY (2008)
Clinical characteristics of exudative age-related macular degeneration in Japanese patients
Ichiro Maruko et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration
Gary C. Brown et al.
OPHTHALMOLOGY (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Risk factors for age related maculopathy in a Japanese population: the Hisayama study
M Miyazaki et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration
S Sharma et al.
OPHTHALMOLOGY (2001)
Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study
JJ Wang et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2000)
Causes of blindness and visual impairment in a population of older Americans -: The Salisbury Eye Evaluation Study
B Muñoz et al.
ARCHIVES OF OPHTHALMOLOGY (2000)
The second eye of Japanese patients with unilateral exudative age related macular degeneration
M Uyama et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2000)
Share Paper
